Licochalcone A induces apoptosis through endoplasmic reticulum stress via a phospholipase Cγ1-, Ca2+-, and reactive oxygen species-dependent pathway in HepG2 human hepatocellular carcinoma cells (Retracted Article)

Licochalcone A induces apoptosis through endoplasmic reticulum stress via a phospholipase Cγ1-, Ca2+-, and reactive oxygen species-dependent pathway in HepG2 human hepatocellular carcinoma cells (Retracted Article)
复制标题

DOI:
10.1007/s10495-013-0955-y
复制
发表时间:
2014-04-01
期刊:
影响因子:
7.2
通讯作者:
Kang, Insug
Kang, Insug
中科院分区:
生物学2区
文献类型:
--
作者:
Choi, A-Young;Choi, Ji Hyun;Kang, Insug

文献摘要

被引文献

相似文献

甘草查尔酮A(LicA)是一种雌激素类黄酮,可诱导多种类型的癌细胞凋亡。在这项研究中,在HepG2人肝癌细胞中研究了LicA抗癌作用的分子机制。LicA诱导凋亡性细胞死亡,半胱天冬酶-4、-9和-3的活化,以及内质网(ER)应激相关蛋白(包括C/EBP同源蛋白(CHOP))的表达。通过CHOP敲低或用ER应激抑制剂salubrinal和4-苯基丁酸处理来抑制ER应激,减少了LicA诱导的细胞死亡。LicA还诱导活性氧(ROS)的积累和抗氧化剂N-乙酰半胱氨酸减少LicA诱导的细胞死亡和CHOP的表达。此外,LicA增加胞浆Ca~(2+)水平,这被2-氨基乙氧基二苯基硼酸酯(1,4,5-三磷酸肌醇受体的拮抗剂)和BAPTA-AM(胞内Ca~(2+)螯合剂)阻断。2-氨基乙氧基二苯基硼酸酯和BAPTA-AM抑制LicA诱导的细胞死亡。有趣的是,LicA诱导磷脂酶C γ 1(PLC γ 1)的磷酸化,并抑制PLC γ 1减少细胞死亡和ER应激。此外,多靶向受体酪氨酸激酶抑制剂索拉非尼和舒尼替尼减少了LicA诱导的细胞死亡、ER应激以及胞质Ca 2+和ROS积累。最后,LicA诱导血管内皮生长因子受体2(VEGFR2)和c-Met受体的磷酸化,并通过VEGFR2和c-Met siRNA共转染抑制这两种受体,逆转了LicA诱导的细胞死亡、Ca2+增加和CHOP表达。总之,这些发现表明,通过PLC γ 1-,Ca2 +-和ROS依赖性途径诱导ER应激可能是LicA诱导HepG2肝癌细胞凋亡的重要机制。
Licochalcone A (LicA), an estrogenic flavonoid, induces apoptosis in multiple types of cancer cells. In this study, the molecular mechanisms underlying the anti-cancer effects of LicA were investigated in HepG2 human hepatocellular carcinoma cells. LicA induced apoptotic cell death, activation of caspase-4, -9, and -3, and expression of endoplasmic reticulum (ER) stress-associated proteins, including C/EBP homologous protein (CHOP). Inhibition of ER stress by CHOP knockdown or treatment with the ER stress inhibitors, salubrinal and 4-phenylbutyric acid, reduced LicA-induced cell death. LicA also induced reactive oxygen species (ROS) accumulation and the anti-oxidant N-acetylcysteine reduced LicA-induced cell death and CHOP expression. In addition, LicA increased the levels of cytosolic Ca2+, which was blocked by 2-aminoethoxydiphenyl borate (an antagonist of inositol 1,4,5-trisphosphate receptor) and BAPTA-AM (an intracellular Ca2+ chelator). 2-Aminoethoxydiphenyl borate and BAPTA-AM inhibited LicA-induced cell death. Interestingly, LicA induced phosphorylation of phospholipase C gamma 1 (PLC gamma 1) and inhibition of PLC gamma 1 reduced cell death and ER stress. Moreover, the multi-targeted receptor tyrosine kinase inhibitors, sorafenib and sunitinib, reduced LicA-induced cell death, ER stress, and cytosolic Ca2+ and ROS accumulation. Finally, LicA induced phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2) and c-Met receptor and inhibition of both receptors by co-transfection with VEGFR2 and c-Met siRNAs reversed LicA-induced cell death, Ca2+ increase, and CHOP expression. Taken together, these findings suggest that induction of ER stress via a PLC gamma 1-, Ca2+-, and ROS-dependent pathway may be an important mechanism by which LicA induces apoptosis in HepG2 hepatocellular carcinoma cells.